Home - High Throughput Mutation Screening for Cancer, Microbes and Drug Resistance
GeneMuDx's newly patented invention, DSF-applied assay, permits simultaneous analysis of hundreds genes in hundreds samples. Researchers are invited to join us to form profit-sharing joint ventures.
mutation screening, minimal residual disease, MRD, drug resistance, infectious microorganisms, gene mutation, cancer, mutant, targeted therapy, molecular diagnosis, molecular assays, polymerase chain reaction, PCR, DNA sequencing, leukemia, lymphomas, amp
Ist das deine Seite? Bestätige deine Seite und aktualisiere die Infos
